Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. The company is headquartered in St. Louis, Missouri and currently employs 61,100 full-time employees. The company went IPO on 2001-12-13. The company provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
The most recent EPS for Centene Corp is $3.37, beating expectations of $2.15.
How did Centene Corp CNC's revenue perform in the last quarter?
Centene Corp revenue for the last quarter is $3.37
What is the revenue estimate for Centene Corp?
According to 16 of Wall street analyst, the revenue estimate of Centene Corp range from $51.98B to $44.64B
What's the earning quality score for Centene Corp?
Centene Corp has a earning quality score of B+/53.510464. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Centene Corp report earnings?
Centene Corp next earnings report is expected in 2026-07-27
What are Centene Corp's expected earnings?
Centene Corp expected earnings is $48.0B, according to wall-street analysts.
Did Centene Corp beat earnings expectations?
Centene Corp recent earnings of $49.94B beat expectations.